Hassett Calls Record Credit Card Spending a Win as Delinquencies Rise and Farm Bankruptcies Surge 46 From Singapore to Brussels World Leaders Eye Potential TrumpXi Summit Micron Advances Memory Technology Dicks Sporting Reports Results Paxton Political Development Qualcomms Recent Stock Rally Signals Growing Investor Confidence in AI Device Expansion Meta Tests AI Subscription Plans Starting at 799 Monthly SpaceX Files for Public Offering Potentially Making Elon Musk a Trillionaire CUE Q3 2025 Earnings Narrower Loss Drives Positive Market Response Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged ADAMH Q1 2026 Earnings Senior Notes Trust Surpasses Estimates with Strong Earnings Surprise MGM Q1 2026 Earnings EPS Miss Triggers Cautious Optimism as Shares Advance YALA Q1 2026 Earnings EPS of 016 Highlights Solid Performance Amid Limited Disclosures Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector LuxExperience LUXE Slides 14 as Selling Pressure Builds Near Support Alamo Group Inc ALG Climbs 163 as Shares Test Key Resistance Near 160 Nuveen Arizona Quality Municipal Income Fund NAZ Holds Steady Near Support Amid Modest Decline Sensient Technologies SXT Shows Resilience with 130 Gain Eyes Resistance at 12430 Nvidia Earnings Call in Focus Market Watches for Commentary on China Chip Restrictions and Geopolitical Tensions Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Movers Singapore Lifts 2026 Export Growth Forecast on AIDriven Demand Prediction Markets Face Mounting Legal Challenges as 16 States Take Action Against Platforms Technical Indicators Point to Bullish Bias in Intermediate Term NY Fed Study Reveals Surge in Food Insecurity Among Vulnerable Americans Iran Intensifies Claims Over Strait of Hormuz with New Map of Armed Forces Oversight Cyngn Inc CYN Q1 2026 Earnings Narrowerthanexpected loss props up shares Trevi Therapeutics TRVI Holds Near Resistance After Modest Gain